Hepatitis C Virus Frequency in Hemodialysis Patients at A Tertiary Care Facility in Rawalpindi, Northern Pakistan
DOI:
https://doi.org/10.51253/pafmj.v74i3.10297Keywords:
anti-HCV, Blood transfusion, Chronic kidney disease, hemodialysisAbstract
Objective: To detect the frequency of anti-HCV antibodies in hemodialysis patients.
Study Design: Cross-sectional study.
Place and Duration of Study: Department of Virology, Armed Forces Institute of Pathology, Rawalpindi Pakistan, from Jul to Dec 2021.
Methodology: One hundred and fifteen patients were selected from the Hemodialysis Centre. Blood samples were taken from patients undergoing hemodialysis to detect anti-HCV by enzyme-linked immunosorbent assay. The samples were spun up and checked for anti-HCV antibodies using the Bio-Rad Monolisa anti-HCV version 3 kit and a 3rd generation ELISA.
Results: A total of 115 patients were tested for anti-HCV. The anti-HCVs in this study were detected in 34(29.56%) patients. The mean duration of hemodialysis was 2.3±1.4 years. Out of 115 patients, 81(70.4%) had no significant history. Of the 34 positive patients, 15(44.2%) had a history of intravascular exposures, 12(35%) had a history of blood transfusion, 3(8.8%) had a history of tooth extraction surgery during the dialysis period, and 4(11%) had a history of minor surgery during dialysis.
Conclusion: The study emphasizes the significant frequency of HCV infection in hemodialysis patients, particularly those with a history of intravenous exposure and blood transfusions.
Downloads
References
Timofte D, Dragos D, Balcangiu-Stroescu AE, Tanasescu MD, Gabriela Balan D, Avino A, et al. Infection with hepatitis C virus in hemodialysis patients: An overview of the diagnosis and prevention rules within a hemodialysis center (Review). Exp Ther Med 2020; 20(1): 109-116.
https://doi.org/10.3892/etm.2020.8606
Ahsan A, Khan AZ, Javed H, Mirza S, Chaudhary SU, Shahzad-Ul-Hussan S. Estimation of hepatitis C prevalence in the Punjab province of Pakistan: A retrospective study on general population. PLoS One 2019; 14(4): e0214435.
https://doi.org/10.1371/journal.pone.0214435
Nouroz F, Shaheen S, Mujtaba G, Noreen S. An overview on hepatitis C virus genotypes and its control. Egypt J Med Hum Genet 2015; 16(4): 291–298.
https://doi.org/10.1016/j.ejmhg.2015.05.003
Khan A, Nadir A, Mushtaq MH, Junaid K, Khan AM, Ali H, et al. Molecular epidemiology and genotype distribution of hepatitis C in Pakistan; a multicenter cross-sectional study. Infect Genet Evol 2020; 84: 104372.
https://doi.org/10.1016/j.meegid.2020.104372
Caragea DC, Mihailovici AR, Streba CT, Schenker M, Ungureanu B, Caragea IN, et al. Hepatitis C Infection in Hemodialysis Patients. Curr Health Sci J 2018; 44(2): 107-112.
https://doi.org/10.12865/CHSJ.44.02.02
Akhtar S, Nasir JA, Usman M, Sarwar A, Majeed R, Billah B. The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: A systematic review and meta-analysis. PLoS One 2020; 15(5) :e0232931.
https://doi.org/10.1371/journal.pone.0232931
Petruzziello A, Marigliano S, Loquercio G, Cacciapuoti C. Hepatitis C virus (HCV) genotypes distribution: an
epidemiological up-date in Europe. Infect Agent Cancer 2016; 11: 53. https://doi.org/10.1186/s13027-016-0099-0
Fabrizi F, Cerutti R, Messa P. Updated Evidence on the Epidemiology of Hepatitis C Virus in Hemodialysis. Pathogens 2021; 10(9): 1149.
https://doi.org/10.3390/pathogens10091149
Basu D, Sharma AK, Gupta S, Nebhinani N, Kumar V. Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in northern India. Indian J Med Res 2015; 142(3): 311-316. https://doi.org/10.4103/0971-5916.166596
Saleem U, Aslam N, Siddique R, Iqbal S, Manan M. Hepatitis C virus: Its frequency, risk factors and genotype distribution in Pakistan. Eur J Inflamm 2022; 20: 17.
https://doi.org/10.1177/1721727X221144391
Jadoul M, Bieber BA, Martin P, Akiba T, Nwankwo C, Arduino JM, et al. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney Int 2019; 95(4): 939-947. https://doi.org/10.1016/j.kint.2018.11.038
Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Fölsch UR, Schmidt WE; PHV Study Group. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut 2002; 51(3): 429-433.
https://doi.org/10.1136/gut.51.3.429
Kerollos KMN, El-Ameen HA, El Wahed LA, Azoz NMA. Frequency and seroconversion of hepatitis C among
hemodialysis patients in Assiut governorate, Egypt. Egypt J Intern Med. 2020; 32: 2. https://doi.org/10.1186/s43162-020-00005-0
Qorbani M, Ghorbani N, Djalalinia S, Modirian M, Abdar Z, Mansourian M, et al. Frequency of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis. J Res Med Sci 2017; 22(1): 123.
Gao Y, Yang J, Sun F, Zhan S, Fang Z, Liu X, et al. Prevalence of Anti-HCV Antibody Among the General Population in Mainland China Between 1991 and 2015: A Systematic Review and Meta-analysis. Open Forum Infect Dis 2019; 6(3): ofz040.
https://doi.org/10.1093/ofid/ofz040
Kannaiyan K, Ragunathan L, Subramanian V, Samuel M, Mahendran M. Serofrequency and risk factors for Hepatitis C virus among maintenance hemodialysis patients at a Tertiary Care Hospital in Puducherry, India. Biomed Biotechnol Res J 2022 ;6(1):122
Khan S, Attaullah S, Ali I, Ayaz S, Naseemullah, Khan SN, et al. Rising burden of Hepatitis C Virus in hemodialysis patients. Virol J 2011; 8: 438. https://doi.org/10.1186/1743-422X-8-438
Lodhi A, Sajjad A, Mehmood K, Lodhi A, Rizwan S, Ubaid A, et al. Profile and predictors of hepatitis and HIV infection in patients on hemodialysis of Quetta, Pakistan. Drug Discov Ther 2019; 13(5): 274-279. https://doi.org/10.5582/ddt.2019.01044
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Muhammad Ali Rathore, Muhammad Khaleeq Saqi, Eijaz Ghani, Saifullah Khan Niazi, faraz ahmed, Hina Hammad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
